Ryan Halsted
Stock Analyst at RBC Capital
(3.81)
# 2,011
Out of 4,692 analysts
98
Total ratings
63.5%
Success rate
9.6%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintained: Buy | $108 | $90.92 | +18.79% | 4 | Aug 28, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $44 | $25.36 | +73.54% | 9 | Aug 27, 2026 | |
| COR Cencora | Initiated Coverage: Hold | $330 | $322.46 | +2.34% | 1 | Aug 19, 2026 | |
| CAH Cardinal Health | Initiated Coverage: Buy | $276 | $235.12 | +17.39% | 1 | Aug 19, 2026 | |
| MCK McKesson | Initiated Coverage: Hold | $845 | $889.39 | -4.99% | 1 | Aug 19, 2026 | |
| EVH Evolent Health | Maintained: Hold | $3 | $4.75 | -36.84% | 6 | Aug 6, 2026 | |
| SHC Sotera Health Company | Reiterated: Buy | $24 | $19.49 | +23.14% | 10 | Aug 6, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $31 | $20.92 | +48.18% | 8 | Aug 6, 2026 | |
| DOCS Doximity | Reiterated: Buy | $28 | $25.51 | +9.76% | 10 | Aug 6, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $215 → $282 | $298.00 | -5.37% | 5 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $46 | $34.81 | +32.15% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $185 | $170.74 | +8.35% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $221 → $247 | $263.32 | -6.20% | 6 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $484 → $692 | $618.12 | +11.95% | 6 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $22.75 | +5.52% | 5 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $11.85 | +60.34% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $12.06 | n/a | 4 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $38.62 | n/a | 1 | Oct 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $83.87 | n/a | 1 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 | $174.39 | n/a | 3 | May 12, 2016 |
HealthEquity
Aug 28, 2026
Maintained: Buy
Price Target: $108
Current: $90.92
Upside: +18.79%
Waystar Holding
Aug 27, 2026
Maintained: Buy
Price Target: $44
Current: $25.36
Upside: +73.54%
Cencora
Aug 19, 2026
Initiated Coverage: Hold
Price Target: $330
Current: $322.46
Upside: +2.34%
Cardinal Health
Aug 19, 2026
Initiated Coverage: Buy
Price Target: $276
Current: $235.12
Upside: +17.39%
McKesson
Aug 19, 2026
Initiated Coverage: Hold
Price Target: $845
Current: $889.39
Upside: -4.99%
Evolent Health
Aug 6, 2026
Maintained: Hold
Price Target: $3
Current: $4.75
Upside: -36.84%
Sotera Health Company
Aug 6, 2026
Reiterated: Buy
Price Target: $24
Current: $19.49
Upside: +23.14%
Privia Health Group
Aug 6, 2026
Reiterated: Buy
Price Target: $31
Current: $20.92
Upside: +48.18%
Doximity
Aug 6, 2026
Reiterated: Buy
Price Target: $28
Current: $25.51
Upside: +9.76%
Charles River Laboratories International
Aug 5, 2026
Maintained: Buy
Price Target: $215 → $282
Current: $298.00
Upside: -5.37%
Aug 5, 2026
Maintained: Buy
Price Target: $53 → $46
Current: $34.81
Upside: +32.15%
Jul 30, 2026
Maintained: Buy
Price Target: $185
Current: $170.74
Upside: +8.35%
Jul 28, 2026
Reiterated: Buy
Price Target: $221 → $247
Current: $263.32
Upside: -6.20%
Jul 23, 2026
Reiterated: Buy
Price Target: $484 → $692
Current: $618.12
Upside: +11.95%
Jul 22, 2026
Reiterated: Hold
Price Target: $24
Current: $22.75
Upside: +5.52%
May 27, 2026
Maintained: Buy
Price Target: $19
Current: $11.85
Upside: +60.34%
Jan 12, 2017
Upgraded: Buy
Price Target: n/a
Current: $12.06
Upside: n/a
Oct 6, 2016
Reiterated: Hold
Price Target: n/a
Current: $38.62
Upside: n/a
Sep 9, 2016
Reiterated: Hold
Price Target: n/a
Current: $83.87
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $22
Current: $174.39
Upside: n/a